Urinary phytoestrogen excretion and prostate cancer risk: a nested case–control study in the Multiethnic Cohort
✍ Scribed by Park, S-Y; Wilkens, L R; Franke, A A; Le Marchand, L; Kakazu, K K; Goodman, M T; Murphy, S P; Henderson, B E; Kolonel, L N
- Book ID
- 110000087
- Publisher
- Nature Publishing Group
- Year
- 2009
- Tongue
- English
- Weight
- 131 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Enterolactone, a phytoestrogen belonging to the class of lignans, is produced by the intestinal microflora from precursors in plant foods and has been implicated in protection against cancer. We study the effect of enterolactone on the risk of a subsequent diagnosis of prostate cancer.
## Objective Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown. ## Methods These questions were investigated in a case–con